GenMont Biotech Incorporation
3164
Rank in Stocks
#23306
Based in Taiwan, GenMont Biotech Incorporation is primarily engaged in the... Based in Taiwan, GenMont Biotech Incorporation is primarily engaged in the comprehensive process of developing, manufacturing, and marketing functional probiotic products. Beyond its core offerings, the company also provides specialized probiotic formulations. It extends its services to include original formula design and production for health-oriented food items, as well as supplying relevant manufacturing equipment. Additionally, GenMont Biotech actively collaborates on the research, production, and clinical evaluation of a variety of other products. The company was established in 2000 and has its headquarters situated in Tainan City, Taiwan.
Share Price
$0.50604201
Last synced: 2026-11-10
Market Cap
$43.52M
Change (1 day)
-0.30%
Change (1 year)
-14.29%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade GenMont Biotech Incorporation (3164)
Category
Healthcare
Operating Margin for GenMont Biotech Incorporation (3164)
Operating Margin as of November 2026 TTM: 7.00%
According to GenMont Biotech Incorporation's latest financial reports, its current operating margin (TTM) is 7.00%. At the end of 2025 the company had an operating margin of 14.39%.
Operating Margin history for GenMont Biotech Incorporation from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.00% | -51.36% |
| 2025 | 14.39% | 38.23% |
| 2024 | 10.41% | 373.18% |
| 2023 | 2.20% | -86.53% |
| 2022 | 16.33% | -51.30% |
| 2021 | 33.53% | 41.60% |
| 2020 | 23.68% | 6.81% |
| 2019 | 22.17% | -26.61% |
| 2018 | 30.21% | 5.45% |
| 2017 | 28.65% | -955.22% |
| 2016 | -3.35% | -61.05% |
| 2015 | -8.60% | -66.37% |
| 2014 | -25.57% | -238.82% |
| 2013 | 18.42% | -241.69% |
| 2012 | -13.00% | 123.75% |
| 2011 | -5.81% | -119.08% |
| 2010 | 30.45% | 11.62% |
| 2009 | 27.28% | 8.30% |
| 2008 | 25.19% | -5.19% |
| 2007 | 26.57% | 30.05% |
| 2006 | 20.43% | -419.22% |
| 2005 | -6.40% | -75.55% |
| 2004 | -26.18% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -94.49% |
US
|
|
| -149.01% | -121.29% |
US
|
|
| 25.57% | -96.35% |
AU
|
|
| 31.23% | -95.54% |
BE
|
|
| 29.35% | -95.81% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about GenMont Biotech Incorporation's operating margin
What is GenMont Biotech Incorporation's operating margin?
GenMont Biotech Incorporation's operating margin is 7.00%, as of Nov 2026.
What was GenMont Biotech Incorporation's operating margin in 2025?
In 2025, GenMont Biotech Incorporation's operating margin was 14.39%, compared with 10.41% in 2024.
How has GenMont Biotech Incorporation's operating margin changed since 2020?
From 2020 to 2025, GenMont Biotech Incorporation's operating margin was highest in 2021 (33.53%) and lowest in 2023 (2.20%).
How does GenMont Biotech Incorporation's operating margin compare with similar companies?
GenMont Biotech Incorporation's operating margin (7.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.